The study looked for an optimal set of genes differentiating between papillary thyroid cancer
(PTC) and normal thyroid tissue and assessed the sources of variability in gene expression …

… We consider these results as highly relevant for therapeutic decision making about patients
with thyroid cancer and, therefore, would recommend a diagnostic algorithm as shown in …

… nodules and cancer according to the individual risk of … Diagnostic and treatment tools have
significantly improved in … to cure thyroid cancer patients: the Italian Thyroid Association (AIT), …

… In conclusion, thyroid cancer diagnosed during pregnancy has been found to be associated
with a poorer prognosis compared to tumors developed in a nongravidic period. Although …

… thyroid cancer, we may often be violating the important dictum primum non nocere. The financial
and emotional costs of thyroid cancer … that patients with thyroid cancer were significantly …

… Recent advancement of molecular diagnosis in thyroid cancer provides more effective
treatment strategies for individual cases. The well known genetic mutation underlying …

… The cytologic diagnosis of ariaplastic thyroid cancer … of thyroid cancer entirely on the basis
of cytologic diagnosis. In combination with scintigraphy, ABC allows highly accurate diagnosis …

… BRAF is found in classic papillary and tall cell thyroid cancer,4 as well as in a third of poorly
differentiated and anaplastic thyroid carcinomas.7 Dedifferentiated thyroid cancer can have …

… risk of differentiated thyroid cancer, including regional/distant disease, following diagnosis
of … The DCR also provided data on thyroid cancer histology and stage at diagnosis. Papillary …

… The mean length of time between the diagnosis of thyroid nodules and thyroid cancer
was 6.0 years; for goiter, it was 11.6 years. No risk was evident following hypothyroidism or …